Who owns Innate Pharma Adr?
- Ticker: IPHA
- CUSIP Number: 45781k204
Tip: Access positions for across all investors
Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Innate Pharma stock
Who bought or sold Innate Pharma Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lion Point Capital | 81k | $149k | 0% | Jun 2026 |
|
| Morgan Stanley | 44k | $56k | -6% | Mar 2026 |
|
| SmartHarvest Portfolios | 24k | $44k | 100% | Jun 2026 |
|
| XTX Topco | 15k | $28k | 100% | Jun 2026 |
|
| Citadel Advisors | 12k | $23k | 100% | Jun 2026 |
|
| Jane Street | 10k | $19k | -76% | Jun 2026 |
|
| Rhumbline Advisers | 4.7k | $8.7k | 0% | Jun 2026 |
|
| UBS Group | 1.4k | $2.5k | 58% | Jun 2026 |
|
| Farther Finance Advisors | 21.00 | $37.999500 | 110% | Jun 2026 |
|
| GAMMA Investing | 9.00 | $17.000100 | -96% | Jun 2026 |
|
Who sold out of Innate Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Mar 2026 | 10k | $13k |